These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36798048)

  • 21. Higher immunoglobulin A nephropathy recurrence in related-donor kidney transplants: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Okada D; Unagami K; Kakuta Y; Iizuka J; Takagi T; Shirakawa H; Omoto K; Ishida H; Tanabe K;
    Int J Urol; 2019 Sep; 26(9):903-909. PubMed ID: 31328329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation.
    Davis S; Gralla J; Klem P; Tong S; Wedermyer G; Freed B; Wiseman A; Cooper JE
    Am J Transplant; 2018 Apr; 18(4):907-915. PubMed ID: 28925597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study.
    Adam R; Karam V; Cailliez V; Trunečka P; Samuel D; Tisone G; Němec P; Soubrane O; Schneeberger S; Gridelli B; Bechstein WO; Risaliti A; Line PD; Vivarelli M; Rossi M; Pirenne J; Klempnauer JL; Rummo A; Di Benedetto F; Zieniewicz K; Troisi R; Paul A; Vali T; Kollmar O; Boudjema K; Hoti E; Colledan M; Pratschke J; Lang H; Popescu I; Ericzon BG; Strupas K; De Simone P; Kochs E; Heyd B; Gugenheim J; Pinna AD; Bennet W; Kazimi M; Bachellier P; Wigmore SJ; Rasmussen A; Clavien PA; Hidalgo E; O'Grady JG; Zamboni F; Kilic M; Duvoux C;
    Transplantation; 2019 Sep; 103(9):1844-1862. PubMed ID: 31343568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols.
    Chkhotua AB; Klein T; Shabtai E; Yussim A; Bar-Nathan N; Shaharabani E; Lustig S; Mor E
    Urology; 2003 Dec; 62(6):1002-6. PubMed ID: 14665344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset acute rejection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Tamura S; Keneko J; Matsui Y; Hasegawa K; Makuuchi M
    World J Gastroenterol; 2006 Nov; 12(41):6674-7. PubMed ID: 17075982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of pediatric kidney transplantation: A single-center experience over the past 34 years in Japan.
    Aoki Y; Hamasaki Y; Satoh H; Matsui Z; Muramatsu M; Hamada R; Harada R; Ishikura K; Hataya H; Honda M; Sakai K; Shishido S
    Int J Urol; 2020 Feb; 27(2):172-178. PubMed ID: 31826334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
    Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ; Kim B; Lee JE; Kim YG; Kim DJ; Kim SJ; Joh JW; Oh HY; Huh W
    Transpl Int; 2010 Feb; 23(2):147-54. PubMed ID: 19744223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation.
    Turgut D; Sayin B; Soy EA; Topcu Dİ; Ozdemir BH; Haberal M
    Saudi J Kidney Dis Transpl; 2021; 32(2):348-354. PubMed ID: 35017328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor pancreas transplantation in Japan.
    Kenmochi T; Asano T; Maruyama M; Saigo K; Akutsu N; Iwashita C; Ohtsuki K; Suzuki A; Miyazaki M
    J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):101-7. PubMed ID: 19618100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot Study.
    Jänigen BM; Gehrmann S; Glatz T; Seidl M; Thomusch O; Prager EP; Zschiedrich S; Fichtner-Feigl S; Pisarski P; Schneider J
    Transplant Proc; 2020 Apr; 52(3):780-784. PubMed ID: 32111386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression.
    Baron PW; Infante S; Peters R; Tilahun J; Weissman J; Delgado L; Kore AH; Beeson WL; de Vera ME
    Ann Transplant; 2017 May; 22():309-314. PubMed ID: 28533501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 37-year kidney transplantation experience at Siriraj Hospital.
    Premasathian N; Vongwiwatana A; Taweemonkongsap T; Amornvesukit T; Limsrichamrern S; Jitpraphai S; Kositamongkol P; Mahawithitwong P; Sritippayawan S; Chanchairujira T; Nualyong C; Vareesangthip K; Vasuvattakul S; Sirivatanauksorn Y
    Clin Transpl; 2010; ():141-8. PubMed ID: 21696037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney transplantation from living donors: comparison of results between related and unrelated donor transplants under new immunosuppressive protocols.
    Chkhotua AB; Klein T; Shabtai EL; Yussim A; Bar-Nathan N; Shaharabani E; Lustig S; Mor E
    Isr Med Assoc J; 2003 Sep; 5(9):622-5. PubMed ID: 14509149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function.
    Liu Y; Liu H; Shen Y; Chen Y; Cheng Y
    Transplant Proc; 2018 Oct; 50(8):2368-2370. PubMed ID: 30316359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.
    Lim WH; Johnson DW; Hawley CM; Pascoe E; Wong G
    Am J Kidney Dis; 2018 Jan; 71(1):102-111. PubMed ID: 29191625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
    Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.